Thyroid hormone and COUP-TF1 regulate kallikrein-binding protein (KBP) gene expression.
Kallikrein-binding protein (KBP) is a component of the kallikrein-kinin system that mediates vasodilation and inhibits tumor growth by antagonizing vascular endothelial growth factor-mediated angiogenesis. We demonstrate that KBP gene expression is repressed by T(3) and modulated by the orphan nuclear receptor, chicken ovalbumin upstream promoter transcription factor 1 (COUP-TF1). In hypothyroid mice, KBP mRNA expression in the testis was increased 2.1-fold compared with euthyroid mice. We have identified two negative thyroid hormone response elements (nTREs) in the mouse KBP gene, nTRE1 located in the 5' flanking region (-53 to -29) and nTRE2, located in the first intron (104-132). We used functional assays, cofactor knockdown, and chromatin immunoprecipitation assays to characterize nTRE1 and nTRE2 in hepatic (HepG2) and testes (GC-1spg) cell lines. Reporter expression directed by both elements was enhanced with addition of thyroid hormone receptor and repressed with the addition of T(3). COUP-TF1 enhanced basal expression of both elements but blunted unliganded thyroid hormone receptor enhancement and T(3) repression of nTRE1 but not nTRE2. Both nTREs bound nuclear corepressor and binding increased in response to T(3). Nuclear corepressor knockdown resulted in loss of T(3) repression of both nTRE1 and nTRE2. COUP-TF1, which usually represses T(3) induction of positive thyroid hormone response elements, reverses T(3) repression mediated by nTRE1 in the mouse KBP gene. Endogenous KBP expression is repressed by T(3) and two functional nTREs, both of which are required, have been characterized in the KBP gene. COUP-TF1 may be an important factor to modulate expression of genes that are repressed by T(3).
Molecular Endocrinology Laboratory, Building 114, Room 230, Veterans Affairs Greater Los Angeles Healthcare System, 11301 Wilshire Boulevard, Los Angeles, California 90073, USA.
Yan-Yun
YY
Liu
Teruyo
T
Nakatani
Takahiko
T
Kogai
Kaizeen
K
Mody
Gregory A
GA
Brent
D000818:Animals; D051838:COUP Transcription Factor I / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D056970:Co-Repressor Proteins / Q000235:genetics / Q000378:metabolism; D005786:Gene Expression Regulation / Q000502:physiology*; D017930:Genes, Reporter; D006801:Humans; D007037:Hypothyroidism / Q000378:metabolism; D051379:Mice; D009154:Mutation; D011485:Protein Binding; D015843:Serpins / Q000235:genetics / Q000378:metabolism*; D014284:Triiodothyronine / Q000235:genetics / Q000378:metabolism*
D051838:COUP Transcription Factor I; D056970:Co-Repressor Proteins; D015843:Serpins; C051324:kallistatin; D014284:Triiodothyronine
Mol Endocrinol. 1997 Jun;11(6):714-24
9171235
Mol Endocrinol. 2000 Dec;14(12):1918-33
11117523
Curr Opin Cell Biol. 1997 Apr;9(2):222-32
9069256
Cancer Lett. 2007 Nov 8;257(1):97-106
17714861
Blood. 2002 Nov 1;100(9):3245-52
12384424
Cell. 1996 May 3;85(3):403-14
8616895
Steroids. 2007 Feb;72(2):165-70
17166537
J Biol Chem. 1992 Sep 15;267(26):18689-94
1527000
Endocr Rev. 1993 Oct;14(5):651-8
8262011
J Biol Chem. 1997 Dec 12;272(50):31465-74
9395481
Mol Endocrinol. 2006 Mar;20(3):483-90
16254015
Mol Endocrinol. 2002 Nov;16(11):2439-51
12403833
Biochim Biophys Acta. 1996 Jul 17;1307(3):285-93
8688463
Keio J Med. 2003 Sep;52(3):174-81
14529150
Mol Cell Biol. 1997 May;17(5):2642-8
9111334
Endocrinology. 2005 Feb;146(2):776-83
15550503
J Biol Chem. 1998 Jun 26;273(26):16391-9
9632703
FASEB J. 1999 Oct;13(13):1839-44
10506588
Recent Prog Horm Res. 1993;48:393-414
8441852
J Biol Chem. 1991 Nov 15;266(32):21666-73
1657975
Thyroid. 2009 Sep;19(9):987-99
19678741
J Biol Chem. 2000 Dec 8;275(49):38457-66
10993887
Mol Cell Biol. 1991 Dec;11(12):6016-25
1944274
J Clin Invest. 1997 Jul 1;100(1):11-7
9202051
Diabetologia. 2003 May;46(5):689-98
12743698
Biochim Biophys Acta. 1997 Sep 12;1353(3):277-86
9349723
Nature. 1995 Oct 5;377(6548):397-404
7566114
Cell. 1996 Nov 29;87(5):953-9
8945521
J Clin Invest. 2005 Sep;115(9):2517-23
16100573
J Clin Invest. 2003 Aug;112(4):497-9
12925689
J Biol Chem. 2005 Apr 15;280(15):14545-55
15701601
J Biol Chem. 1992 Dec 25;267(36):25873-80
1334488
J Clin Invest. 2003 Aug;112(4):588-97
12925699
J Biol Chem. 2001 Jan 12;276(2):1276-84
11016932
N Engl J Med. 1994 Sep 29;331(13):847-53
8078532
EMBO J. 2001 Nov 1;20(21):6071-83
11689447
Nature. 1995 Oct 5;377(6548):454-7
7566127
EMBO J. 1999 Oct 1;18(19):5389-98
10508171
Nature. 1997 May 1;387(6628):43-8
9139820
Mol Endocrinol. 1991 Apr;5(4):542-8
1922086
J Mol Endocrinol. 2006 Jun;36(3):517-30
16720720
Mol Cell Biol. 1992 Oct;12(10):4666-76
1328857
J Biol Chem. 1999 Aug 6;274(32):22345-53
10428804
Biochemistry. 2006 Nov 7;45(44):13150-62
17073437
J Biol Chem. 1993 Nov 15;268(32):24498-505
8227002
J Biol Chem. 1990 Sep 25;265(27):16394-401
2398056
New Biol. 1991 Dec;3(12):1206-19
1667479
Mol Endocrinol. 2009 May;23(5):600-9
19196836
Immunopharmacology. 1996 May;32(1-3):67-72
8796269
Endocr Rev. 1997 Apr;18(2):229-40
9101138
Nature. 1997 May 1;387(6628):49-55
9139821
Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1448-52
1311101
Nat Clin Pract Nephrol. 2007 Apr;3(4):208-21
17389890
J Steroid Biochem Mol Biol. 1999 Nov;71(1-2):1-19
10619353
Cell. 2000 Dec 8;103(6):843-52
11136970
Biochim Biophys Acta. 1991 Dec 2;1129(1):127-30
1756173
J Biol Chem. 2003 Jan 10;278(2):732-8
12419821
Dev Biol. 2004 Feb 15;266(2):238-51
14738874
Cell. 1991 Jun 28;65(7):1255-66
1648450
J Steroid Biochem Mol Biol. 1996 Jan;56(1-6 Spec No):81-5
8603050
Nature. 1997 Sep 11;389(6647):194-8
9296499
J Biol Chem. 1989 Jan 5;264(1):178-82
2909514
Annu Rev Physiol. 1991;53:17-35
2042958